{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:35:42Z","timestamp":1787924142641,"version":"build-2784847793"},"reference-count":80,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,28]],"date-time":"2027-08-28T00:00:00Z","timestamp":1819411200000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104978","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:25:58Z","timestamp":1782491158000},"page":"104978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PF5190457 reduces fentanyl intake and seeking with a low risk pharmacological profile in male rats"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8830-4863","authenticated-orcid":false,"given":"Christina R.","family":"Merritt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7065-6748","authenticated-orcid":false,"given":"Leah M.","family":"Salinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-7048","authenticated-orcid":false,"given":"Erik J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly L.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3012-8236","authenticated-orcid":false,"given":"Jennifer J.","family":"Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Gerard Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle C.","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.104978_bib1","author":"Ahmad"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatr Res Clin Pract"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jpet.2026.104978_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/appi.ajp.20220312","article-title":"Risk of experiencing an overdose event for patients undergoing treatment with medication for opioid use disorder","volume":"180","author":"Brandt","year":"2023","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jpet.2026.104978_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2023.100251","article-title":"Association of opioid use disorder with outcomes of hospitalizations for acute myocardial infarction in the United States","volume":"78","author":"Ascandar","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41398-023-02591-3","article-title":"Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders","volume":"13","author":"Houghton","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bja.2018.03.009","article-title":"Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis","volume":"120","author":"Higgins","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpet.2026.104978_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"10.1016\/j.jpet.2026.104978_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40263-014-0178-y","article-title":"Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy","volume":"28","author":"Engel","year":"2014","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ijms18020273","article-title":"From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation","volume":"18","author":"Howick","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104978_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.irn.2017.08.002","article-title":"The role of the ghrelin system in drug addiction","volume":"136","author":"Zallar","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104978_bib15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/WNR.0000000000001071","article-title":"Accumbal ghrelin and glucagon-like peptide 1 signaling in alcohol reward in female rats","volume":"29","author":"Abtahi","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpet.2026.104978_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbr.2013.03.049","article-title":"Microinjection of ghrelin in the nucleus accumbens core enhances locomotor activity induced by cocaine","volume":"248","author":"Jang","year":"2013","journal-title":"Behav Brain Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.104978_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4236\/jbbs.2013.38060","article-title":"Microinjection of ghrelin into the ventral tegmental area potentiates cocaine-induced conditioned place preference","volume":"3","author":"Schuette","year":"2013","journal-title":"J Behav Brain Sci"},{"issue":"11","key":"10.1016\/j.jpet.2026.104978_bib18","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/ijms18112486","article-title":"Alterations in rat accumbens endocannabinoid and GABA content during fentanyl treatment: the role of ghrelin","volume":"18","author":"Sustkova-Fiserova","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104978_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1268366","article-title":"Ghrelin receptor antagonist JMV2959 blunts cocaine and oxycodone drug-seeking, but not self-administration, in male rats","volume":"14","author":"Merritt","year":"2023","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12845","article-title":"Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats","volume":"25","author":"Sustkova-Fiserova","year":"2020","journal-title":"Addict Biol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib21","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1074\/jbc.M111.288324","article-title":"High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs","volume":"287","author":"Damian","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tem.2022.12.001","article-title":"Ghrelin receptor signaling in health and disease: a biased view","volume":"34","author":"Gross","year":"2023","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41467-022-27975-9","article-title":"Molecular mechanism of agonism and inverse agonism in ghrelin receptor","volume":"13","author":"Qin","year":"2022","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.jpet.2026.104978_bib24","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1016\/j.bmcl.2012.05.024","article-title":"Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor","volume":"22","author":"Kung","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.jpet.2026.104978_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/ml400473x","article-title":"Discovery of PF-5190457, a potent, selective, and orally bioavailable ghrelin receptor inverse agonist clinical candidate","volume":"5","author":"Bhattacharya","year":"2014","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"10.1016\/j.jpet.2026.104978_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bph.13439","article-title":"Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo","volume":"173","author":"Kong","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bcp.13127","article-title":"Pharmacokinetics and pharmacodynamics of PF-05190457: the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects","volume":"83","author":"Denney","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jpet.2026.104978_bib28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41386-021-01249-2","article-title":"Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral \u03b21 receptors","volume":"47","author":"You","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41380-018-0064-y","article-title":"The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study","volume":"25","author":"Lee","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/npp.2013.199","article-title":"Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence","volume":"39","author":"Anastasio","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.131","article-title":"Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity","volume":"4","author":"Anastasio","year":"2014","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/cn300072u","article-title":"Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction","volume":"4","author":"Cunningham","year":"2013","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"10.1016\/j.jpet.2026.104978_bib33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/acschemneuro.6b00413","article-title":"Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats","volume":"8","author":"Neelakantan","year":"2017","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/jpet.118.251199","article-title":"The 5-HT2A receptor (5-HT2AR) regulates impulsive action and cocaine cue reactivity in male Sprague-Dawley rats","volume":"368","author":"Sholler","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.104978_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.bbi.2020.03.003","article-title":"Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats","volume":"87","author":"Ezeomah","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2011.04.034","article-title":"Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues","volume":"61","author":"Cunningham","year":"2011","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.jpet.2026.104978_bib37","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1523\/JNEUROSCI.16-23-07416.1996","article-title":"Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system","volume":"16","author":"Tella","year":"1996","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/00006450-200101000-00013","article-title":"Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups","volume":"49","author":"Lohmann","year":"2001","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1056-8719(97)00050-6","article-title":"Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine","volume":"38","author":"Pinelli","year":"1997","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ejo\/24.1.107","article-title":"Emotional stress and brux-like activity of the masseter muscle in rats","volume":"24","author":"Rosales","year":"2002","journal-title":"Eur J Orthod"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098336","article-title":"Immune responses and hypercoagulation in ERT for Pompe disease are mutation and rhGAA dose dependent","volume":"9","author":"Nayak","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.104978_bib43","series-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. 5th ed, revised and expanded","author":"Gabrielsson","year":"2023"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.npp.1300851","article-title":"Cue-induced brain activity changes and relapse in cocaine-dependent patients","volume":"31","author":"Kosten","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2026.104978_bib45","article-title":"A protocol for measuring cue reactivity in a rat model of cocaine use disorder","volume":"136","author":"Dimet","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jpet.2026.104978_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2016.02.052","article-title":"Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system","volume":"324","author":"Swinford-Jackson","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.jpet.2026.104978_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1360-0443.2009.02843.x","article-title":"Abuse liability of intravenous buprenorphine\/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers","volume":"105","author":"Comer","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","article-title":"A preclinical comparison between different opioids: antinociceptive versus adverse effects","volume":"80","author":"Meert","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.npp.1300599","article-title":"Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory","volume":"30","author":"Panlilio","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00213-005-2192-8","article-title":"A paradigm to investigate the self-regulation of cocaine administration in humans","volume":"180","author":"Sughondhabirom","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpet.2026.104978_bib51","series-title":"Nonclinical Assessment of Abuse Potential for New Pharmaceuticals","first-page":"245","article-title":"Regulatory framework and guidance to the evaluation of the abuse liability of drugs in the United States and Europe","author":"Calderon","year":"2015"},{"issue":"7","key":"10.1016\/j.jpet.2026.104978_bib52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics","volume":"90","author":"Jamison","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpet.2026.104978_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/bjp.2008.100","article-title":"Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction","volume":"154","author":"Christie","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2026.104978_bib54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1515\/REVNEURO.2005.16.3.255","article-title":"The motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective","volume":"16","author":"Frenois","year":"2005","journal-title":"Rev Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.102.034827","article-title":"Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure","volume":"302","author":"Banks","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.20823","article-title":"Expression of ghrelin receptor mRNA in the rat and the mouse brain","volume":"494","author":"Zigman","year":"2006","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib59","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/ijms18030638","article-title":"Is ghrelin synthesized in the central nervous system?","volume":"18","author":"Cabral","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104978_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molmet.2018.09.007","article-title":"Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor","volume":"18","author":"Rhea","year":"2018","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-328X(97)00071-5","article-title":"Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues","volume":"48","author":"Guan","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.104978_bib62","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1523\/JNEUROSCI.1151-21.2021","article-title":"Complexes of ghrelin GHS-R1a, GHS-R1b, and dopamine D1 receptors localized in the ventral tegmental area as main mediators of the dopaminergic effects of ghrelin","volume":"42","author":"Navarro","year":"2022","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1369-1600.2006.00041.x","article-title":"Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens","volume":"12","author":"Jerlhag","year":"2007","journal-title":"Addict Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1369-1600.2006.00002.x","article-title":"Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward","volume":"11","author":"Jerlhag","year":"2006","journal-title":"Addict Biol"},{"issue":"3\u20134","key":"10.1016\/j.jpet.2026.104978_bib65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1369-1600.2008.00125.x","article-title":"Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine","volume":"13","author":"Jerlhag","year":"2008","journal-title":"Addict Biol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104978_bib66","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1172\/JCI29867","article-title":"Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite","volume":"116","author":"Navarro","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1369-1600.2011.00396.x","article-title":"A limited role for ghrelin in heroin self-administration and food deprivation-induced reinstatement of heroin seeking in rats","volume":"17","author":"Maric","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.jpet.2026.104978_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2017.09.013","article-title":"Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats","volume":"110","author":"Jerabek","year":"2017","journal-title":"Neurochem Int"},{"issue":"14","key":"10.1016\/j.jpet.2026.104978_bib69","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00213-014-3466-9","article-title":"Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats","volume":"231","author":"Sustkova-Fiserova","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib70","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1038\/s41467-024-49655-6","article-title":"Author correction: associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jpet.2026.104978_bib71","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.celrep.2015.06.062","article-title":"Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jpet.2026.104978_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tips.2004.01.010","article-title":"Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation","volume":"25","author":"Holst","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpet.2026.104978_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-12-381296-4.00006-3","article-title":"Ghrelin receptor: high constitutive activity and methods for developing inverse agonists","volume":"485","author":"Els","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jpet.2026.104978_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101187","article-title":"A new understanding of GHSR1a\u2013independent of ghrelin activation","volume":"64","author":"Xiao","year":"2020","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib75","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00726-012-1355-2","article-title":"The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist","volume":"44","author":"Moulin","year":"2013","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib76","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1096\/fj.201800655R","article-title":"Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists","volume":"33","author":"Ramirez","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.jpet.2026.104978_bib77","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.jmedchem.1c02191","article-title":"Advances in the development of nonpeptide small molecules targeting ghrelin receptor","volume":"65","author":"Giorgioni","year":"2022","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104978_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001393","article-title":"Initial pharmacological characterization of a major hydroxy metabolite of PF-5190457: inverse agonist activity of PF-6870961 at the ghrelin receptor","volume":"386","author":"Deschaine","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104978_bib79","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s42003-024-06303-5","article-title":"Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet","volume":"7","author":"Leko","year":"2024","journal-title":"Commun Biol"},{"issue":"24","key":"10.1016\/j.jpet.2026.104978_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182331","article-title":"A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder","volume":"9","author":"Faulkner","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpet.2026.104978_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2018.07.004","article-title":"Pharmacological manipulation of the ghrelin system and alcohol hangover symptoms in heavy drinking individuals: is there a link?","volume":"172","author":"Farokhnia","year":"2018","journal-title":"Pharmacol Biochem Behav"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652601178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:15:59Z","timestamp":1787922959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652601178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S002235652601178X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104978","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PF5190457 reduces fentanyl intake and seeking with a low risk pharmacological profile in male rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104978"}}